To evaluate NRF2-dependent regulation of these genes, we generated two KEAP1-mutant NSCLC cell lines (A549 and NCI-H460) stably integrated with a doxycycline (dox)-inducible shRNA targeting NRF2. Here, KEAP1 is linked to non-small cell lung carcinoma.